Iranian Private Sector to Mass-Produce Fatty Liver, Slimming Medicine
13:00 - May 29, 2024

Iranian Private Sector to Mass-Produce Fatty Liver, Slimming Medicine

TEHRAN (ANA)- The head of the research institute of medicinal plants of the Academic Center for Education, Culture and Research said that they have transferred the technical know-how of the drugs to treat addiction, Alzheimer's, fatty liver, slimming and fat burning medicine to the private sector.
News ID : 6096

“We have transferred technical know-how of making four anti-addiction drugs, Alzheimer's treatment drug, fatty liver treatment drug and slimming and fat-burning drug to the private sector,” Qaffarzadegan said.

"We have tried to hand over the products whose Technology Readiness Levels (TRL) have reached a suitable level and can be supplied to the private sector,” he added.

In a relevant development in March, an Iranian knowledge-based company had also begun industrial production of herbal-therapeutic capsules for digestive and liver diseases after receiving finances from Saman Health Research and Technology Fund.

"We produce three types of herbal-therapeutic capsules, including Pipergin (containing ginger), Licorice Cap and Liverful capsules,” Fatemeh Hassanzadeh Aval, managing director of an Iranian knowledge-based company, told Iranian media.

She considered licorice extract as the main component of licorice cap herbal capsule, adding, "This capsule is used to regulate digestive secretions and protect against stomach ulcers, while pipergin herbal capsule with black pepper fruit product and ginger rhizome strengthen digestion, treat indigestion and capsule Liverful which is produced from thistle seeds, dandelion roots, and Plantago psyllium seeds which are used to protect the liver, regulate liver enzymes, and control fatty liver diseases.”

The managing director of the knowledge-based company said his company was financed by the Saman Health Research and Technology Fund, adding, “Our team was able to use the industrial production facilities of the Saman Health Research and Technology Fund to cover part of the production costs of these three herbal medicines.”

“These capsules will cause no side effects and can replace chemical antacid drugs and can be widely used to treat and resolve digestive and liver problems," Hamidreza Farhadi, the managing director of Saman fund, said.

“The therapeutic effects of these capsules are better than other similar foreign-made products. In the meantime, the Iran-made capsules have lower price in comparison with the imported ones. Also, the Iranian products have met standards from the country's Food and Drug Organization,” Farhadi continued.

4155/v

 

Send comment